1. Home
  2. CRDL vs GMGI Comparison

CRDL vs GMGI Comparison

Compare CRDL & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Golden Matrix Group Inc.

GMGI

Golden Matrix Group Inc.

HOLD

Current Price

$0.63

Market Cap

115.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDL
GMGI
Founded
2017
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
115.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRDL
GMGI
Price
$1.05
$0.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.00
$4.00
AVG Volume (30 Days)
328.2K
223.0K
Earning Date
11-13-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$179,142,103.00
Revenue This Year
N/A
$25.59
Revenue Next Year
N/A
$14.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
37.24
52 Week Low
$0.77
$0.58
52 Week High
$1.59
$2.50

Technical Indicators

Market Signals
Indicator
CRDL
GMGI
Relative Strength Index (RSI) 59.15 34.72
Support Level $0.94 $0.65
Resistance Level $1.03 $0.74
Average True Range (ATR) 0.05 0.06
MACD 0.00 -0.01
Stochastic Oscillator 85.71 22.58

Price Performance

Historical Comparison
CRDL
GMGI

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About GMGI Golden Matrix Group Inc.

Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.

Share on Social Networks: